AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. BNTX
  4. [6-K] BioNTech SE American Depositary Share Current Report (Foreign Issuer)

[6-K] BioNTech SE American Depositary Share Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source:

Stock BNTX logo
BIONTECH

NASDAQ:BNTX

BNTX Rankings

#494 Ranked by Market Cap
N/A Ranked by Dividends

BNTX Latest News

Aug 27, 2025
Pfizer and BioNTech鈥檚 COMIRNATY庐 Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
Aug 4, 2025
BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update
Jul 25, 2025
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union
Jul 21, 2025
BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025
Jul 17, 2025
BioNTech Announces Ryan Richardson to Step Down from the Management Board

BNTX Latest SEC Filings

Aug 27, 2025
[6-K] BioNTech SE American Depositary Share Current Report (Foreign Issuer)
Aug 15, 2025
[144] BioNTech SE American Depositary Share SEC Filing
Aug 15, 2025
[144] BioNTech SE American Depositary Share SEC Filing
Aug 11, 2025
[6-K] BioNTech SE American Depositary Share Current Report (Foreign Issuer)
Aug 4, 2025
[6-K] BioNTech SE American Depositary Share Current Report (Foreign Issuer)

BNTX Stock Data

25.26B
89.69M
62.69%
23.08%
2.52%
Biotechnology
Healthcare
Germany
Mainz